1. Home
  2. VABK vs CCCC Comparison

VABK vs CCCC Comparison

Compare VABK & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virginia National Bankshares Corporation

VABK

Virginia National Bankshares Corporation

HOLD

Current Price

$40.47

Market Cap

203.8M

Sector

Finance

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$2.73

Market Cap

240.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VABK
CCCC
Founded
1998
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
203.8M
240.3M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
VABK
CCCC
Price
$40.47
$2.73
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$8.50
AVG Volume (30 Days)
9.1K
1.4M
Earning Date
10-23-2025
11-06-2025
Dividend Yield
3.56%
N/A
EPS Growth
14.22
N/A
EPS
3.30
N/A
Revenue
$56,512,000.00
$30,108,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$12.28
N/A
Revenue Growth
10.39
N/A
52 Week Low
$33.66
$1.09
52 Week High
$44.57
$5.10

Technical Indicators

Market Signals
Indicator
VABK
CCCC
Relative Strength Index (RSI) 60.53 62.08
Support Level $38.11 $2.29
Resistance Level $39.38 $2.63
Average True Range (ATR) 0.90 0.15
MACD 0.13 0.03
Stochastic Oscillator 100.00 92.41

Price Performance

Historical Comparison
VABK
CCCC

About VABK Virginia National Bankshares Corporation

Virginia National Bankshares Corp is a bank holding company which is engaged in the commercial and retail banking business. The bank offers a range of banking and related financial services, including checking accounts, negotiable order of withdrawal accounts, money market deposit accounts, certificates of deposit, individual retirement accounts and other depository services. Its segments include the Bank, VNB Trust and Estate Services, Sturman Wealth Advisors, and Masonry Capital. The Bank's commercial banking activities involve making loans, taking deposits and offering related services to individuals, businesses, and charitable organizations.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: